Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Dupilumab may cause hair loss, so patients should be monitored.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Tofacitinib may help treat severe hair loss, but more research is needed.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

308 nm excimer phototherapy can help some people with alopecia areata regrow hair, especially if their condition is less severe.

High concentration Minoxidil and Carboxygas effectively treated resistant hair loss with no side effects.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Corticosteroids may effectively regrow hair in Alopecia Totalis with manageable side effects.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Hydroxychloroquine effectively treated twenty-nail dystrophy in a patient with alopecia areata.

Higher RBP4 levels found in people with two types of hair loss.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

Antioxidants can help improve hair growth in people with alopecia areata.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.